JHEP Reports

Papers
(The H4-Index of JHEP Reports is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Increased carbohydrate deficient transferrin: Whisky or candy?176
Reply to: “Hepatic bile acid transport increases in the postprandial state: A functional 11C-CSar PET/CT study in healthy humans”161
Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites”124
Combined inhibition of bile salt synthesis and intestinal uptake reduces cholestatic liver damage and colonic bile salts in mice119
Copyright and information115
The weight of choices: Prioritizing lifestyle over GLP-1 receptor agonist therapy in managing MASLD114
Erratum to “Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis” [JHEP Reports 6 (2024) 100949]110
Reply to: “Dynamic imaging of macrophages in MASLD: A major interest in insulin resistance and outside the liver”90
AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool77
Identifying emergency presentations of chronic liver disease using routinely collected administrative hospital data73
Development and validation of circulating protein signatures as diagnostic biomarkers for biliary tract cancer73
Mapping the hemodynamic effects of terlipressin in patients with hepatorenal syndrome using advanced magnetic resonance imaging65
JMJD2D stabilises and cooperates with HBx protein to promote HBV transcription and replication61
Changing epidemiology of hepatocellular carcinoma in the Mediterranean area: A challenge for surveillance?59
Emerging roles of circular RNAs in liver cancer58
Heterogeneity in intrahepatic macrophage populations and druggable target expression in patients with steatotic liver disease-related fibrosis56
Induction of phospholipase A2 group 4C by HCV infection regulates lipid droplet formation56
Epigenetics of alcohol-related liver diseases54
What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association53
Protective role of physical activity against HCC risk in type 2 diabetes: Evidence and public health perspectives51
Copyright and information50
Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis46
Lower pretreatment HBV DNA levels are associated with better off-treatment outcomes after nucleo(s)tide analogue withdrawal in patients with HBeAg-negative chronic hepatitis B: A multicentre cohort st46
A small animal model of chronic hepatitis E infection using immunocompromised rats44
Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis43
Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis42
External validation of the IAIHG autoimmune hepatitis response criteria in a multicentric real-world cohort41
Liver stiffness measurement predicts clinical outcomes in autoimmune hepatitis41
HCV microelimination in harm reduction centres has benefits beyond HCV cure but is hampered by high reinfection rates40
Hepatitis C virus replication requires integrity of mitochondria-associated ER membranes40
Predicting liver ablation volumes with real-time MRI thermometry40
Editorial Board page39
Potential role of liver-resident CD3+ macrophages in HBV clearance in a mouse hepatitis B model38
Copyright and information38
Xanthine oxidase promotes hepatic lipid accumulation through high fat absorption by the small intestine37
All-cause and disease-specific mortality in young adults with MASLD: A nationwide cohort study36
Fluctuating biomarkers in primary sclerosing cholangitis: A longitudinal comparison of alkaline phosphatase, liver stiffness, and ELF36
0.034060955047607